Skip to content
Clinical Trials – home
Janssen Vaccines & Prevention B.V.
Sponsor

Janssen Vaccines & Prevention B.V.

The Netherlands Archimedesweg 4-6, 2333 CN Leiden, The Netherlands

About the sponsor

Janssen Vaccines & Prevention B.V. focuses on the prevention of invasive extraintestinal pathogenic Escherichia coli disease in older adults, with particular attention to infections arising from ExPEC O-serotypes linked to bloodstream and sterile-site infection.

  • Invasive ExPEC disease
  • Escherichia coli infection prevention
  • Older adult infectious disease risk

The company’s research activity is concentrated in adult populations with prior urinary tract infection history and other groups at elevated risk for severe bacterial disease.

About Specializations

Janssen Vaccines & Prevention B.V. runs clinical trials in conditions such as Escherichia infection, Escherichia urinary tract infection, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Escherichia infection

Not recruiting

Study on the Safety and Immune Response of JNJ-78901563 and High-dose Influenza Vaccine in Preventing E. coli Infections in Adults Aged 65 and Older

Registered drug
Countries:BelgiumBelgium
  • Participants:65+ years · Healthy volunteers
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Study of ExPEC9V vaccine for preventing invasive E.

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.